N-(1-((6-chloro-5-nitropyridin-3-yl)methyl)imidazolidin-2-ylidene)nitramide

ID: ALA2287962

PubChem CID: 136244997

Max Phase: Preclinical

Molecular Formula: C9H9ClN6O4

Molecular Weight: 300.66

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=[N+]([O-])/N=C1\NCCN1Cc1cnc(Cl)c([N+](=O)[O-])c1

Standard InChI:  InChI=1S/C9H9ClN6O4/c10-8-7(15(17)18)3-6(4-12-8)5-14-2-1-11-9(14)13-16(19)20/h3-4H,1-2,5H2,(H,11,13)

Standard InChI Key:  CXXGDPNBMSXXBY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
   17.6425  -23.5871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6413  -24.3530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3824  -24.7330    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.1251  -24.3525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1223  -23.5835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3806  -23.2071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8614  -23.2011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6037  -23.5781    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6959  -24.3367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5331  -24.4912    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.9596  -23.8355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3857  -23.2717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8962  -24.7321    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   20.0616  -24.8483    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.2423  -25.5934    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.0599  -25.8282    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.6103  -26.1064    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.9035  -23.1388    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1529  -23.5505    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.9277  -22.2848    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  8  1  0
  2 13  1  0
  9 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 18 19  2  0
 18 20  1  0
  1 18  1  0
M  CHG  4  15   1  17  -1  18   1  20  -1
M  END

Alternative Forms

  1. Parent:

    ALA2287962

    ---

Associated Targets(non-human)

Periplaneta americana (513 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
nAChRalpha5 Nicotinic acetylcholine receptor alpha 5 subunit (134 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 300.66Molecular Weight (Monoisotopic): 300.0374AlogP: 0.60#Rotatable Bonds: 4
Polar Surface Area: 126.80Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 0.47CX LogD: 0.47
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.49Np Likeness Score: -0.98

References

1. Nishimura K, Kiriyama K, Kagabu S.  (2006)  Quantitative structureactivity relationships of imidacloprid and its analogs with substituents at the C5 position on the pyridine ring in the neuroblocking activity,  31  (2): [10.1584/jpestics.31.110]

Source